These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6355014)

  • 1. Experience with biosynthetic human insulin in diabetes.
    Kruger DF; Whitehouse FW; Kahkonen DM; Partamian JO; Fachnie JD; Goldman J; Leach D
    Henry Ford Hosp Med J; 1983; 31(2):72-6. PubMed ID: 6355014
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and immunogenicity of human and monocomponent porcine insulin: a randomized double-blind study in diabetic patients previously treated with insulin.
    Storms GE; Lutterman JA; van 't Laar A
    Neth J Med; 1986; 29(10):296-302. PubMed ID: 3540688
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of bovine, porcine and semisynthetic human insulin.
    Venekamp WJ; van der Hooft JC; Jacobsen L; van Schaik CL
    Neth J Med; 1985; 28 Suppl 1():57-8. PubMed ID: 3892343
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

  • 5. [12 month's therapy with biosynthetic human insulin. Results of a double-blind comparative study with swine and bovine insulin in insulin-dependent diabetics during a multicenter study].
    Beyer J; Haas R; Enzmann F; Lauerbach M; Rademacher J; Althoff PH; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Heun K; Kerp L; Lotz N; Mehnert H; Mitzkat HJ; Petersen K; Rosak C; Sailer D; Schlüter K; Schöffling K; Schröder KE; Schumm P
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S69-79. PubMed ID: 6408438
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies to insulin in patients with diabetes mellitus].
    Kozopolianskaia MM; Poltorak VV; Stetsenko KP
    Vrach Delo; 1973 Feb; 2():110-2. PubMed ID: 4722307
    [No Abstract]   [Full Text] [Related]  

  • 7. Monocomponent insulin in maturity onset diabetes mellitus.
    Viswanathan M; Ramachandran A; Snehalatha C; Viswanathan M
    J Indian Med Assoc; 1981 Mar; 76(5):73-5. PubMed ID: 7021694
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of insulin antibodies in insulin treated patients.
    Giampietro O; Giannessi D; Del Chicca MG; Luche AD; Zucchelli GC; Navalesi R
    J Nucl Med Allied Sci; 1980; 24(3-4):153-8. PubMed ID: 7019394
    [No Abstract]   [Full Text] [Related]  

  • 9. [The study of insulin antibodies in different forms of diabetes mellitus].
    Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin resistant diabetes mellitus.
    Zhu XX; Wang ZG; Qiu CL; Zhong XL
    Chin Med J (Engl); 1980 Nov; 93(11):737-44. PubMed ID: 6775883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 12. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
    Göbel P; Kramer W; Heni F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunogenic properties of a highly purified insulin preparation.
    Manning NT; Drury MI
    Ir J Med Sci; 1979 Apr; 148(4):135-9. PubMed ID: 393651
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetes mellitus. Its treatment with monocompound purified insulin].
    Mirouze J; Orsetti A; Schmouker Y; Cartry E; Almes N
    Nouv Presse Med; 1973 Sep; 2(30):1981-5. PubMed ID: 4738370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin antibodies in diabetes.
    Lev-Ran A; Joshua H; Mannheimer S
    Isr J Med Sci; 1971 Sep; 7(9):1035-9. PubMed ID: 5170197
    [No Abstract]   [Full Text] [Related]  

  • 17. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of antibodies on the activity and kinetics of administered insulin].
    Páv J; Srámková J
    Cas Lek Cesk; 1982 Oct; 121(41):1258-61. PubMed ID: 6756634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monocomponent insulins].
    Rodríguez-Miñón JL
    Minerva Med; 1977 Jul; 68(35):2485-90. PubMed ID: 887227
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.